-
Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
09 Dec 2024 12:13 GMT
… cell lung cancer
Nearly 2.5 million lung cancer cases … lung cancer medicines and the next wave of innovations, including osimertinib and gefitinib … improvements for people with lung cancer, including and beyond … non-small cell lung cancers and its correlation …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … portfolio includes leading lung cancer medicines and the … (osimertinib) and Iressa (gefitinib); Imfinzi and Imjudo; Enhertu … improvements for people with lung cancer, including and beyond …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Small cell lung cancer
Lung cancer is the … lung cancer medicines and the next wave of innovations, including osimertinib and gefitinib … people with lung cancer, including … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer …
-
Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations
25 Nov 2024 11:17 GMT
… oncogenic drivers in lung cancers to select targeted drugs … Effectiveness of gefitinib against non – small-cell lung cancer with the … with non-small cell lung cancer. Lung Cancer. 2015;87(2 … cell lung cancer: new evidence and treatment. Transl Lung Cancer Res. …
-
Advances in the Treatment of Rare Mutations in Non-Small Cell Lung Cancer
20 Nov 2024 07:57 GMT
… small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) … comparing the efficacy of gefitinib and platinum-based … non-small cell lung cancer; SCLC, small cell lung cancer; EGFR, epidermal … Receptor Kinase Fusion-Positive Lung Cancers. JCO Precis Oncol. …
-
Japan Lung Cancer Market Set To Skyrocket To US$ 9,376.83 Million By 2032 | Astute Analytica
06 Nov 2024 14:01 GMT
… over 10 million lung cancer screenings annually through … of targeted therapies like gefitinib and osimertinib, improving … in precision medicine improve lung cancer treatment options. Government … Small Cell Lung Cancer Non-small Cell Lung Cancer Lung Carcinoid …
-
Current Status and Future Prospects of TROP-2 ADCs in Lung Cancer Treatment
05 Nov 2024 16:00 GMT
… Characteristics of Patients with Lung Cancer
Lung cancer is a complex and … in the treatment of lung cancers, and a clinical … al. Gefitinib or chemotherapy for non-small-cell lung cancer with … novel therapeutic approach in lung cancer. Lung Cancer. 2022;163:96– …
-
Bio-Inspired Nanodelivery Platform: Platelet Membrane-Cloaked Genistein Nanosystem for Targeted Lung Cancer Therapy
16 Oct 2024 07:51 GMT
… platform, the lung cancer targeting ability, therapeutic … tumors, including lung cancer.
Acknowledgments
We … Therapy for Lung Cancer Treatment. Anticancer … gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer …
-
ctDNA SNORD3F Hypermethylation is a Prognostic Indicator in EGFR-TKI-Treated Advanced Non-Small Cell Lung Cancer
11 Oct 2024 11:51 GMT
… was addressed by lung-cancer-specific methylation profiling RNA … for first-line gefitinib treatment in patients … Nucleolar RNA 71A Promotes Lung Cancer Cell Proliferation, Migration … nucleolar RNA signatures of lung tumor-initiating cells. Mol Cancer …
-
Innovent and Ask Pharm join forces to commercialize third-generation lung cancer therapy Patient centricity
08 Oct 2024 13:05 GMT
… pipeline in the field of lung cancer, which can form advantageous … the way non-small cell lung cancer (NSCLC) is treated, allowing … approved for the treatment of lung cancer. The most advanced drugs … efficacy and safety compared to gefitinib in the first-line …